Personalized Nutrition And Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Ingredient (Proteins & Amino Acid, Vitamins, Minerals, Probiotics, Herbal/Botanic), By Dosage Form (Tablets/Capsules, Liquids, Powders, Other), By End Use (Supermarkets/Hypermarkets, Specialty Stores, Retail Pharmacies, Online Pharmacies & E-Commerce Sites), By Region & Competition, 2021-2031F

May 2026 | 180 pages | ID: PA4C28F632C5EN
TechSci Research

US$ 4,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Personalized Nutrition And Supplements Market is projected to experience substantial growth, expanding from USD 54.72 Billion in 2025 to USD 118.98 Billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.82%. This market focuses on delivering customized dietary advice and formulated products, meticulously designed to cater to an individual's distinct biological and lifestyle requirements, often identified through advanced genetic, microbiome, or biomarker testing. Key drivers for this expansion include the rising global incidence of chronic lifestyle diseases and a significant industry-wide pivot towards preventive healthcare. Furthermore, swift progress in diagnostic technologies facilitates highly accurate assessments of individual nutrient needs, thereby fostering the market's evolution beyond conventional, mass-produced offerings.

Market Driver

The market is fundamentally being reshaped by the integration of Artificial Intelligence and big data into nutritional diagnostics, which processes intricate biological datasets to advance precision health. Diverging from conventional approaches, AI algorithms now analyze extensive microbiome, genetic, and metabolic data to formulate highly specific dietary interventions, thereby transitioning the industry from broad advice to biologically targeted solutions. This technological prowess attracts considerable investment, as exemplified by Viome Life Sciences securing $25 million in Series D funding in September 2024 to launch its diagnostic division and expand its AI-driven preventative health technologies, highlighting the crucial role of advanced data analytics in bringing personalized nutrition to a wider consumer base. Simultaneously, the widespread adoption of wearable health technology and self-monitoring devices serves as a key data acquisition engine, supplying continuous, real-time physiological feedback essential for dynamic personalization. These devices monitor metrics like heart rate variability, sleep quality, and activity, establishing a feedback loop that enables nutrition providers to adapt recommendations based on an individual’s daily performance and recovery. The commercial success of this trend is underscored by Garmin Ltd.'s 2024 fitness segment revenue growth of 31% year-over-year to $1.77 billion, driven by robust demand for advanced wearables. This surge in hardware adoption aligns directly with consumer expectations for tailored health solutions, with 69% of supplement users emphasizing the importance of personalized regimens, validating the strong connection between technological engagement and customized care.

Market Challenge

Regulatory complexity presents a substantial barrier to the growth of the global personalized nutrition and supplements market. Companies leveraging sensitive biological data for tailored products must navigate a fragmented legal environment, characterized by disparate data privacy regulations and inconsistent scientific validation standards across various jurisdictions. This lack of regulatory harmonization necessitates significant compliance investments, which in turn inflate operational costs and postpone the introduction of innovative diagnostic tools into international markets. Moreover, the absence of a consistent framework for validating testing methods introduces ambiguity, thereby diminishing consumer trust. Without clear regulatory benchmarks, prospective users often find it difficult to differentiate between scientifically validated personalized solutions and generic alternatives, resulting in reluctance to adopt. This confusion surrounding industry oversight is quantifiable and negatively impacts market penetration; in 2025, 52% of voters incorrectly believed the dietary supplement category was unregulated or were uncertain of its regulatory status, according to the Consumer Healthcare Products Association. Such statistics demonstrate how an unclear and intricate regulatory landscape fosters distrust, directly hindering the industry's capacity to translate consumer interest into sustained market expansion.

Market Trends

The adoption of 3D-printing technology for customized dosage forms is transforming nutrient delivery by surmounting conventional manufacturing constraints. This innovation facilitates the creation of "polypills" containing multiple ingredients encapsulated in distinct layers, which enhances bioavailability and patient adherence. In contrast to mass-produced supplements, 3D printing enables real-time dosage adjustments informed by biological data, thereby fostering a dynamic supply chain. The rapid growth of this sector is exemplified by specialized manufacturers, with Rem3dy Health reporting an average annual revenue increase of 100.04% over three years, highlighting the shift towards personalized manufacturing. Concurrently, the emergence of Femtech-driven personalized hormonal nutrition is addressing metabolic fluctuations linked to fertility and menopause. This trend transcends generic multivitamins, favoring phasic supplementation protocols that align nutrient intake with specific hormonal shifts. This targeted methodology is drawing considerable investment, as investors acknowledge the strong demand for biologically specific solutions. The Femtech market, for instance, saw a 55% year-over-year increase in 2024, propelled by innovations that prioritize women's physiological needs. This robust investment activity signifies a maturing ecosystem where personalized nutrition plays a pivotal role in managing hormonal health.

Key Market Players
  • Amway Corporation
  • Superior Supplements Inc
  • Metagenics, Inc.
  • Nutralliance, Inc.
  • Archer Daniels Midland Company
  • Viome Life Sciences, Inc.
  • DNAFit Life Sciences Ltd
  • Abbott Laboratories Inc
  • Herbalife International of America, Inc.
  • GX Sciences, LLC
Report Scope

In this report, the Global Personalized Nutrition And Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
  • Personalized Nutrition And Supplements Market, By Ingredient
    • Proteins & Amino Acid
    • Vitamins
    • Minerals
    • Probiotics
    • Herbal/Botanic
  • Personalized Nutrition And Supplements Market, By Dosage Form
    • Tablets/Capsules
    • Liquids
    • Powders
    • Other
  • Personalized Nutrition And Supplements Market, By End Use
    • Supermarkets/Hypermarkets
    • Specialty Stores
    • Retail Pharmacies
    • Online Pharmacies & E-Commerce Sites
  • Personalized Nutrition And Supplements Market, By Region
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • United Kingdom
      • Italy
      • Germany
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Personalized Nutrition And Supplements Market.

Available Customizations:

Global Personalized Nutrition And Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL PERSONALIZED NUTRITION AND SUPPLEMENTS MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Ingredient (Proteins & Amino Acid, Vitamins, Minerals, Probiotics, Herbal/Botanic)
  5.2.2. By Dosage Form (Tablets/Capsules, Liquids, Powders, Other)
  5.2.3. By End Use (Supermarkets/Hypermarkets, Specialty Stores, Retail Pharmacies, Online Pharmacies & E-Commerce Sites)
  5.2.4. By Region
  5.2.5. By Company (2025)
5.3. Market Map

6. NORTH AMERICA PERSONALIZED NUTRITION AND SUPPLEMENTS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Ingredient
  6.2.2. By Dosage Form
  6.2.3. By End Use
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Personalized Nutrition And Supplements Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Ingredient
      6.3.1.2.2. By Dosage Form
      6.3.1.2.3. By End Use
  6.3.2. Canada Personalized Nutrition And Supplements Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Ingredient
      6.3.2.2.2. By Dosage Form
      6.3.2.2.3. By End Use
  6.3.3. Mexico Personalized Nutrition And Supplements Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Ingredient
      6.3.3.2.2. By Dosage Form
      6.3.3.2.3. By End Use

7. EUROPE PERSONALIZED NUTRITION AND SUPPLEMENTS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Ingredient
  7.2.2. By Dosage Form
  7.2.3. By End Use
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Personalized Nutrition And Supplements Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Ingredient
      7.3.1.2.2. By Dosage Form
      7.3.1.2.3. By End Use
  7.3.2. France Personalized Nutrition And Supplements Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Ingredient
      7.3.2.2.2. By Dosage Form
      7.3.2.2.3. By End Use
  7.3.3. United Kingdom Personalized Nutrition And Supplements Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Ingredient
      7.3.3.2.2. By Dosage Form
      7.3.3.2.3. By End Use
  7.3.4. Italy Personalized Nutrition And Supplements Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Ingredient
      7.3.4.2.2. By Dosage Form
      7.3.4.2.3. By End Use
  7.3.5. Spain Personalized Nutrition And Supplements Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Ingredient
      7.3.5.2.2. By Dosage Form
      7.3.5.2.3. By End Use

8. ASIA PACIFIC PERSONALIZED NUTRITION AND SUPPLEMENTS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Ingredient
  8.2.2. By Dosage Form
  8.2.3. By End Use
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Personalized Nutrition And Supplements Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Ingredient
      8.3.1.2.2. By Dosage Form
      8.3.1.2.3. By End Use
  8.3.2. India Personalized Nutrition And Supplements Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Ingredient
      8.3.2.2.2. By Dosage Form
      8.3.2.2.3. By End Use
  8.3.3. Japan Personalized Nutrition And Supplements Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Ingredient
      8.3.3.2.2. By Dosage Form
      8.3.3.2.3. By End Use
  8.3.4. South Korea Personalized Nutrition And Supplements Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Ingredient
      8.3.4.2.2. By Dosage Form
      8.3.4.2.3. By End Use
  8.3.5. Australia Personalized Nutrition And Supplements Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Ingredient
      8.3.5.2.2. By Dosage Form
      8.3.5.2.3. By End Use

9. MIDDLE EAST & AFRICA PERSONALIZED NUTRITION AND SUPPLEMENTS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Ingredient
  9.2.2. By Dosage Form
  9.2.3. By End Use
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Personalized Nutrition And Supplements Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Ingredient
      9.3.1.2.2. By Dosage Form
      9.3.1.2.3. By End Use
  9.3.2. UAE Personalized Nutrition And Supplements Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Ingredient
      9.3.2.2.2. By Dosage Form
      9.3.2.2.3. By End Use
  9.3.3. South Africa Personalized Nutrition And Supplements Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Ingredient
      9.3.3.2.2. By Dosage Form
      9.3.3.2.3. By End Use

10. SOUTH AMERICA PERSONALIZED NUTRITION AND SUPPLEMENTS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Ingredient
  10.2.2. By Dosage Form
  10.2.3. By End Use
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Personalized Nutrition And Supplements Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Ingredient
      10.3.1.2.2. By Dosage Form
      10.3.1.2.3. By End Use
  10.3.2. Colombia Personalized Nutrition And Supplements Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Ingredient
      10.3.2.2.2. By Dosage Form
      10.3.2.2.3. By End Use
  10.3.3. Argentina Personalized Nutrition And Supplements Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Ingredient
      10.3.3.2.2. By Dosage Form
      10.3.3.2.3. By End Use

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL PERSONALIZED NUTRITION AND SUPPLEMENTS MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Amway Corporation
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Superior Supplements Inc
15.3. Metagenics, Inc.
15.4. Nutralliance, Inc.
15.5. Archer Daniels Midland Company
15.6. Viome Life Sciences, Inc.
15.7. DNAFit Life Sciences Ltd
15.8. Abbott Laboratories Inc
15.9. Herbalife International of America, Inc.
15.10. GX Sciences, LLC

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER



More Publications